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Abstract
Background: Tobacco smokers are more susceptible to periodontitis than non-smokers but exhibit reduced signs of clinical
inflammation. The underlying mechanisms are unknown. We have previously shown that cigarette smoke extract (CSE)
represents an environmental stress to which P. gingivalis adapts by altering the expression of several virulence factors –
including major and minor fimbrial antigens (FimA and Mfa1, respectively) and capsule – concomitant with a reduced pro-
inflammatory potential of intact P. gingivalis.
Methodology/Principal Findings: We hypothesized that CSE-regulation of capsule and fimbrial genes is reflected at the
ultrastructural and functional levels, alters the nature of host-pathogen interactions, and contributes to the reduced pro-
inflammatory potential of smoke exposed P. gingivalis. CSE induced ultrastructural alterations were determined by electron
microscopy, confirmed by Western blot and physiological consequences studied in open-flow biofilms. Inflammatory
profiling of specific CSE-dysregulated proteins, rFimA and rMfa1, was determined by quantifying cytokine induction in
primary human innate and OBA-9 cells. CSE up-regulates P. gingivalis FimA at the protein level, suppresses the production of
capsular polysaccharides at the ultrastructural level, and creates conditions that promote biofilm formation. We further
show that while FimA is recognized by TLR2/6, it has only minimal inflammatory activity in several cell types. Furthermore,
FimA stimulation chronically abrogates the pro-inflammatory response to subsequent TLR2 stimulation by other TLR-2-
specific agonists (Pam3CSK4, FSL, Mfa1) in an IkBa- and IRAK-1-dependent manner.
Conclusions/Significance: These studies provide some of the first information to explain, mechanistically, how tobacco
smoke changes the P. gingivalis phenotype in a manner likely to promote P. gingivalis colonization and infection while
simultaneously reducing the host response to this major mucosal pathogen.
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Introduction
Tobacco smokers are more susceptible than non-smokers to
multiple infectious diseases, particularly mucosal infections such as
tuberculosis, pneumonia, Chlamydiasis, gonorrhoea, otitis media
and periodontitis [1]. The mechanisms underlying such increased
susceptibility are not well understood. Several groups have shown
that tobacco smoke as well as individual smoke components induce
physiological and structural changes, e.g. reduction of mucociliary
clearance [2,3], and dysregulate specific elements of immune
function, e.g. inhibition of the respiratory burst and phagocytosis
[4,5,6] and interference in antigen presentation [7,8]. However, the
influence of tobacco on bacterial virulence is, essentially, unstudied.
Periodontitis is a bacteria-induced, irreversible chronic inflam-
matory mucosal disease characterized by the destruction of the soft
and hard supporting structures of the teeth. Tobacco smokers are
more susceptible than non-smokers to infections with periodontal
pathogens [1], are more likely to develop severe periodontitis and to
prove refractory to treatment [9]. Paradoxically, smokers show
reduced clinical signs of inflammation in response to dental plaque
than non-smokers, particularly the key diagnostic indices of gingival
bleeding on probing and edema [9,10]. Again, the mechanisms
underlying this phenomenon are poorly characterized.
Porphyromonas gingivalis, a Gram negative, asaccharolytic anaer-
obe, is a key periodontal pathogen whose numbers are increased in
tobacco smokers [9,10]. There is some evidence that components
of tobacco smoke augment P. gingivalis pathogenesis. Nicotine and
its primary metabolite, cotinine, have been shown to increase the
lethality of cell-free extracellular toxins and cell lysates from P.
gingivalis in the chick embryo model [11,12]. The combination of
benzopyrene, a tobacco smoke aryl hydrocarbon, and P. gingivalis
lipopolysaccharide (LPS) significantly increase the inhibition of
osteogenesis in a rat bone marrow cell model compared to either
agonist alone [13].
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environmental stress presented by cigarette smoke extract (CSE)
by altering the expression of several genes and outer membrane
proteins [14]. Concomitant with this adaptive response to CSE, P.
gingivalis induces a lower inflammatory response (TNF-a, IL-6 and
IL-12 p40) from human innate cells compared to unexposed,
control bacteria [14]. Furthermore, the inflammation-inducing
potential of P. gingivalis is restored when cells are sub-cultured back
into fresh medium without CSE. Interestingly, microarray analyses
determined that specific genes (PG2133 and PG2134) in operons
coding for the synthesis and assembly of major and minor fimbrial
antigens (FimA and Mfa1) of P. gingivalis were induced on exposure
to CSE, while several genes in the capsular biosynthesis locus
(capK, PG0117, PG0118 and wecC) were suppressed [14].
It is important to note that capsule polysaccharides and major
fimbrial protein will be the two P. gingivalis features that first
engage the host response and, thus, are likely to play critical roles
in directing initial host-pathogen interactions. Capsule production
is associated with tissue invasiveness [15] and has been reported to
be inversely related to biofilm growth [16], while capsular
polysaccharides represent potent cytokine-inducing stimuli [17].
The major fimbrial antigen, FimA, is also an important virulence
factor that facilitates the adhesion and initial attachment of P.
gingivalis to junctional epithelial cells, thus aiding sub-gingival
colonization [18]. FimA appears to signal via TLR2 and induces
the expression of several pro-inflammatory cytokines such as TNF-
a, IL-6 and IL-1b in innate immune cells [19]. However, the
potency of FimA as a pro-inflammatory agonist is controversial
[20,21,22,23]. Thus, alterations in P. gingivalis capsule and fimbriae
production would be expected to exert marked effects on virulence
and host-pathogen interaction.
We hypothesized that CSE-regulation of capsule and fimbrial
genes is reflected at the ultrastructural and functional levels, alters
the nature of host-pathogen interactions, and contributes to the
reduced pro- inflammatory potential of smoke exposed P. gingivalis.
We establish that CSE up-regulates P. gingivalis FimA at the protein
level, suppresses the production of capsular polysaccharides at the
ultrastructural level, and creates conditions that promote biofilm
formation. We further show that while FimA is recognized by
TLR2/6, it has only minimal inflammatory activity in several cell
types (PBMCs, neutrophils, and epithelial cells) and, furthermore,
FimA stimulation chronically abrogates the pro-inflammatory
response to subsequent TLR2 stimulation by other TLR2-specific
agonists (Pam3CSK4, Mfa1) in an IRAK-1-dependent but NF-
kB-independent manner. These studies provide some of the first
information to explain, mechanistically, how tobacco smoke
changes the P. gingivalis phenotype in a manner likely to promote
P. gingivalis colonization and infection while simultaneously
reducing the host response to this major mucosal pathogen.
Results
Tobacco smoke exposure alters expression of P. gingivalis
fimbriae and capsule
Our previous microarray data indicated that CSE induced the
expression of genes key to the synthesis and assembly of FimA
(PG2133 and PG2134), concomitant with a suppression of several
genes in capsular biosynthesis locus (capK, PG0117, PG0118 and
wecC) [14]. We now show that CSE-exposure reversibly increases
FimA protein, as shown in Figures 1A and B. Transmission
electron micrographs clearly establish that these CSE-regulated
transcriptional and translational activities are reflected at the
ultrastructural level, as shown in Figures 1C and 1D.
Furthermore, CSE-induced FimA is both surface exposed, as
assessed by availability to FimA-specific antibodies (Figure 1F),
and functional, as assessed by binding to the established FimA
ligand, fibronectin [24] (Figure 1E).
CSE augments P. gingivalis biofilm formation
Biofilms play an important role in the pathology of periodontal
disease by mechanisms that include protection of plaque bacteria
against phagocytosis and against antibiotics [25]. FimA plays a
critical role in P. gingivalis biofilm formation. Indeed, P. gingivalis
strains lacking FimA cannot form biofilms [26]. Furthermore,
capsule synthesis has been shown to inversely correlate with
biofilm growth [16]. To establish if our initial discoveries - that
CSE upregulates FimA production while downregulating capsule
production [14] - influence biofilm formation, CSE-exposed and
unexposed P. gingivalis was grown in an open flow biofilm system.
Representative biofilm images are presented in Figure 2A-B.
There was a significant increase in overall homotypic biofilm
formation in the presence of CSE (Table 1), with increased
biomass, substratum coverage, and maximum and mean thickness
apparent (all p,0.01).
FimA and Mfa1 exhibit differential pro-inflammatory
potential
While the innate response to the major fimbrial antigen of P.
gingivalis, FimA, has been partially characterized [27], the
inflammatory potential of the minor fimbrial antigens are not
well understood. Therefore, to better understand the relevance of
CSE-upregulation of FimA and Mfa1, particularly in the context
of the reduced inflammatory response to plaque that is consistently
observed in human smokers [28], we quantified the cytokine
production elicited by these predominant, CSE-regulated surface
antigens in PBMC’s (Figure 3A-C), neutrophils (Figure 3D) and
gingival epithelial cells (Figure 3E). While FimA did promote a
cytokine response from each cell type tested, the concentration of
pro-inflammatory cytokines induced (TNF-a; IL-6; IL-8) was
minimal when compared to the classic bacterial-derived pro-
inflammatory agonists, LPS and Pam3CSK4. In contrast, FimA
did induce high levels of the anti-inflammatory cytokine, IL-10
(Figure 3C). Mfa1, on the other hand, induced a robust pro-
inflammatory response that was comparable or greater in
magnitude to that of LPS in PBMC’s (Figures 3A and 3B),
neutrophils (Figure 3D) and epithelial cells (Figure 3E). These
results are similar to those seen with intact bacteria. We have
previously shown that whole, smoke-exposed P. gingivalis exhibit
reduced inflammatory potential than control (unexposed) cells, as
measured by decreased induction of multiple pro-inflammatory
cytokines (TNF-a, IL-6 and IL-12 p40) [29]. We extend these
observations to show that CSE-exposed P. gingivalis induces
increased IL-10 secretion from innate cells, compared to
unexposed bacteria (Figure 3F).
FimA and Mfa1 are TLR2-specific agonists
In order to understand the differential pro-inflammatory
potential of FimA and Mfa1 at the mechanistic level, we first
established the TLR-specificity of each of these two CSE-
dysregulated P. gingivalis surface proteins. IL-8 production by
rFimA or rMfa1 stimulated HEK293 cells stably expressing
variant TLRs was quantified. As shown in Figure 4A, significantly
higher levels of IL-8 were produced by HEK clones expressing
TLR2/1 and, particularly, TLR2/6 compared to all other clones
(both p.0.001).
As FimA induced lower levels of pro-inflammatory cytokines in
innate immune cells than Mfa1, we hypothesized that FimA may
Tobacco and P. gingivalis
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cell model, FimA and Mfa1 each proved to be effective inducers of
NF-kB transcription (see Figure 4B).
FimA induces TLR2-specific innate tolerance
We next examined if exposure to low-activity FimA influenced
cytokine production (IL-6, TNF-a) in PBMCs on subsequent TLR
stimulation by potent pro-inflammatory agonists (Mfa1 and the
TLR2/1 and TLR2/6 specific agonists, Pam3CSk4 and FSL
respectively). Pre-incubation with FimA inhibited cytokine pro-
duction in response to all TLR2 specific agonists tested, as shown
in Figure 5. Thus, FimA induces a state of inflammatory hypo-
responsiveness in PBMCs. TLR2 surface expression by PBMCs in
response to FimA stimulation was monitored by flow cytometry.
There was no significant difference in TLR2 surface expression
levels up to 24 hrs post-FimA engagement (data not shown). Thus,
FimA stimulation does not alter surface expression of TLR2 in
PBMCs.
FimA stimulation does not induce IkBa degradation but
inhibits IkBa degradation by Mfa1
NF-kB transcription factors are complexed with IkB proteins in
the cytosol. On receiving specific, but varied, extracellular signals
IkBa is phosphorylated and targeted for proteasome-mediated
degradation, resulting in the release and nuclear translocation of
transcriptionally effective NF-kB [9,10,30,31,32,33]. We com-
pared Ik-Ba protein levels in PBMCs exposed to rMfa1, with or
without pre-incubation with rFimA. As shown in Figure 6, while
the potent pro-inflammatory agonist, Mfa1, induced rapid and
extensive Ik-Ba degradation, pre-incubation with rFimA efficient-
ly abrogated this Mfa1-triggered Ik-Ba degradation. Thus, FimA
appears to promote TLR2 hyposensitivity by inhibiting TLR2
agonist-induced degradation of Ik-Ba. Essentially identical results
were found for a second TLR2 agonist, FSL (data not shown).
FimA induced innate tolerance is IRAK-1-mediated
To further understand mechanisms underlying FimA-induced
TLR hypo-responsiveness, we monitored cytosolic IRAK-M and
IRAK-1 in PBMCs. In unstimulated PBMCs, exposure to TLR2
agonists resulted in the rapid (within minutes) degradation of the
upstream NF-kB regulator, IRAK-1, as shown for Mfa1 in
Figure 7A. However, FimA stimulation not only degraded IRAK-
1, without leading to induction of pro-inflammatory cytokine
production (Figure 3) but IRAK-1 levels remained minimal 24
hours after FimA stimulation and, therefore, unavailable for
signaling on secondary TLR2 stimulation, as is shown for Mfa1 in
Figure 1. CSE induces phenotypic surface changes in P. gingivalis. (A) Typical Western blot of FimA in lysates of 1610
6 P. gingivalis cells
sequentially passaged in GAM, GAM-CSE, and then fresh GAM, respectively. (B) Typical relative band intensities establish that FimA expression is
increased on CSE-exposure, but that FimA expression reverts to control levels upon sub-culturing P. gingivalis back into fresh GAM. Representative
transmission electron images of P. gingivalis grown in GAM (C) or GAM-CSE (D). The black arrow indicates the P. gingivalis capsule, which is greatly
reduced in presence of CSE. These CSE-induced phenotypic changes are concomitant with an increased binding of P. gingivalis to the FimA ligand,
fibronectin (E) and surface availability of FimA (F).
doi:10.1371/journal.pone.0009323.g001
Tobacco and P. gingivalis
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(data not shown).
Discussion
Smokers are more susceptible to periodontitis and exhibit more
severe disease, yet the normally overt inflammatory response to
plaque bacteria is suppressed [14]. We have previously shown that
human monocytes challenged with tobacco smoke-exposed P.
gingivalis respond with reduced levels of pro-inflammatory
cytokines [14] and now show that tobacco smoke-exposed P.
gingivalis promote increased IL-10 production. However, the
specific mechanisms of tobacco-induced innate immune suppres-
sion remain unknown. Initial microarray data suggested that
cigarette smoke extract suppressed the production of P. gingivalis
capsular polysaccharides while promoting the expression of
fimbrial proteins [24,34]. As both capsular polysaccharides and
fimbrial proteins of this key periodontal pathogen have been
reported to influence cytokine production and because these
specific bacterial structures will be the first to engage the host
response, we hypothesized that such smoke-induced changes to P.
gingivalis surface may contribute to the lower pro-inflammatory
potential of smoke-exposed bacteria.
We have herein established that tobacco smoke increases
expression of FimA, the major fimbrial protein, reduces P. gingivalis
capsular layer, and promotes the growth of P. gingivalis biofilms of
increased biomass. FimA has been shown to play a critical role in
P. gingivalis colonization of the periodontium through strong
interactions with several host proteins, including collagen, laminin
and fibronectin [35], and by promoting adherence to the oral
epithelia [26] and to other plaque bacteria, such as Streptococcus spp.
[36,37]. Furthermore, it has been long established that biofilms
represent immunoprotective structures. FimA is an important
player in P. gingivalis biofilm formation [38]. Indeed, FimA
deficient strains show reduced biofilm formation [16], while
non-encapsulated mutants of P. gingivalis W83 exhibit enhanced
biofilm formation [1,39,40]. These results are clearly in keeping
with, and provide mechanisms to support, established clinical
observations that show that, compared to non-smokers, smokers
are more likely to be infected with P. gingivalis [41,42], to harbor
higher numbers of P. gingivalis [41], and for such P. gingivalis
infections to be more persistent [43].
Table 1. Quantitative characteristics of P. gingivalis biofilms.
48h Biofilm Biomass (mm
3/mm
2) Substratum coverage (mm
2) Average thickness (mm)
P. gingivalis GAM 1.86961.15 0.31560.11 2.50560.443
P. gingivalis GAM-CSE 5.70860.38*** 0.67960.06 12.6661.487**
Composite image data were analyzed using Matlab softwares to obtain biomass, average thickness; and substratum coverage of 48 h homotypic P. gingivalis biofilms
formed with GAM and GAM-CSE.
**p,0.01; ***p,0.001.
doi:10.1371/journal.pone.0009323.t001
Figure 2. Visualization of homotypic biofilm formation by P. gingivalis grown in GAM or CSE. 48 hr P. gingivalis biofilms, formed in an
open flow system, were stained with FITC. Optical sections were obtained along the x-y and z axis at 1 mm intervals. (A) and (B) are representative
images of biofilms formed in GAM or GAM-CSE, respectively. Top panels represent x-y images while the bottom panel shows x-z stacks, reflecting
biofilm thickness formed in GAM or GAM-CSE, respectively. Z-stack images were obtained from 5 randomly selected fields per biofilm and image data
recorded along the x-y-z planes.
doi:10.1371/journal.pone.0009323.g002
Tobacco and P. gingivalis
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with TLR2 [21,23,44,45]. However, the capacity of FimA to
subsequently elicit an inflammatory response is controversial.
Some research groups have shown that FimA induces the
production of pro-inflammatory cytokines from mononuclear
innate cells [34,45] and have hypothesized that this contributes
to the development of pathological inflammation [21,44,46].
However, other studies suggest that the pro-inflammatory response
to FimA in mononuclear innate cells may be significantly lower
than that expected from comparable doses of classic TLR agonists
[22] and is unlikely to play a major role in P. gingivalis-induced
inflammation [47]. Moreover, it has even been suggested that
FimA may be anti-inflammatory [28]. We now show that the CSE
upregulated P. gingivalis fimbrial proteins, rFimA and rMfa1, each
signal though TLR2/1, and particularly, TLR 2/6; both strongly
activate NF-kB transcription; but that rFimA induces a minimal
pro-inflammatory cytokine (TNF-a, IL-6) response in multiple
innate cell types (human PBMCs, neutrophils and gingival
epithelial cells) compared to rMfa1 and to classic TLR2 agonists;
and also induces significant quantities of the potent anti-
inflammatory cytokine, IL-10. These results mimic the cytokine
profiles that we have previously shown in innate cells stimulated
with intact, CSE-exposed P. gingivalis [9,10,48]. Furthermore, these
observations are in keeping with multiple in vivo studies in smokers
which have shown that, despite increased susceptibility to plaque-
induced periodontitis, the inflammatory response is suppressed in
smokers compared to non-smokers [49,50,51,52]. This inflamma-
tory suppression is reflected in lower concentrations of pro-
inflammatory mediators (IL-1b, IL-6 and, perhaps, TNF-a)i nt h e
gingival crevicular fluid and periodontal tissues of smokers,
compared to non-smokers [53,54]. Inefficient TLR stimulation
and the promotion of a less vigorous inflammatory response is an
established means of immune evasion for several pathogens,
including Bordetella Shigella and pathogenic Escherichia [55,56,57,58].
While CSE induces functional, surface-exposed FimA expres-
sion, we further demonstrate in PBMCs that FimA induces a state
of hyporesponsiveness, or tolerance, to secondary stimulation with
Mfa1, and other TLR2 specific agonists - as demonstrated by an
ablation of TNF-a and IL-6. This FimA-induced hyporesponsive-
ness was not associated with an alteration to TLR2 expression on
the surface of innate cells. Rather, we show that FimA-induced,
TLR2-specific tolerance is mediated by a suppression of Ik-Ba
degradation, which is expected to be concomitant with reduced
Nf-kB translocation.
TLR2 activation leads to the rapid recruitment of MyD88 to
TLR2 and the subsequent recruitment of IRAK-1 and IRAK-4
[59,60]. IRAK-4 phosphorylates IRAK-1 that is in association
with TLR2, allowing IRAK-1 to interact with TRAF6 [56]. This
Figure 3. Inflammatory potential of rFimA and rMfa1. 0.5610
6 primary human PBMCs were stimulated with 1 mg/ml of rFimA, rMfa1 or the
TLR2 and -4 specific agonists Pam3CSK4 and E. coli LPS, respectively. (A) TNF-a; (B) IL-6; and (C) IL-10 release was quantified by ELISA in 20 hr cell-free
supernatants, harvested by centrifugation. (D) 0.5610
6 primary human neutrophils were stimulated with 1 mg/ml of rFimA, rMfa1, Pam3CSK4 or E. coli
LPS. IL-8 release was quantified in 20 hr cell-free supernatants by ELISA.(E) Confluent OBA-9 epithelial cells (,0.4610
6) were stimulated with 1 mg/ml
of rFimA, rMfa1, Pam3CSK4 or E. coli LPS. IL-8 release was quantified in 20 hr cell-free supernatants by ELISA. (F) Similarly to purified FimA, whole, CSE-
exposed P. gingivalis also induced increased IL-10 secretion from primary human PBMCs compared to control bacteria. *p,0.05; **p,0.01;
***p,0.001.
doi:10.1371/journal.pone.0009323.g003
Tobacco and P. gingivalis
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induction of multiple pro-inflammatory cytokine genes [61]. We
show, however, that stimulation with FimA leads to rapid IRAK-1
degradation and the long-term unavailability of this positive
regulator of the TLR-2/MyD88 pathway, helping to explain
FimA-induced tolerance. IRAK-M is a negative regulator of NF-
kB translocation that acts by preventing the dissociation of IRAK-
1 and IRAK4 from MyD88 [62]. While FimA stimulation also
leads to the rapid degradation and chronic suppression of IRAK-
M, this would appear inconsequential with respect to NF-kB
activation because of the unavailability of IRAK-1.
This FimA-induced, IRAK-1- and IkBa-involved suppression of
TLR2 pro-inflammatory cytokine signaling provides one mechanism
by which tobacco smoke dysregulates the inflammatory response
and suppresses cytokine production in smokers. This mechanism of
suppression may be similar to what has been previously reported for
Pam3CSK4 [62]. Monocytes stimulated with Pam3CSK4 have
been shown to be refractory to secondary stimulation with the same
agonist [28]. This occurs due to reduced IRAK-1 protein in these
cells, just as we show in FimA-tolerized PBMCs.
It is important to note that there are limitations inherent in
using recombinant proteins, particularly as they may behave
differently outside the context of the whole bacterium and because
of potential vector-specific alterations in the processing of the
recombinant protein. The advantages, however, are that recom-
binant technology is long established and allows simple purifica-
tion of a large amount of protein that can be readily characterized,
is free of accessory molecules (such as associated fimbrial proteins
FimB through E) and allows for effective and reproducible
elucidation of signaling pathways. It is important to note that
FimA and Mfa1 are simultaneously expressed [19,38], raising the
possibility that Mfa1 may nullify the anti-inflammatory effective-
ness of FimA. However, FimA-comprised fimbriae are much
longer appendages than the minor Mfa1 fimbriae [19,38] and are,
thus, likely to interact with host cells prior to Mfa1. Furthermore,
it has been suggested that FimA appendages may be shed from the
P. gingivalis surface [63] further increasing the likelihood of early
FimA host interaction. Importantly, intact CSE-exposed P.
gingivalis that, presumably, express both Mfa1 and FimA, exhibit
similar anti-inflammatory properties to recombinant FimA. While
Figure 4. rFimA and rMfa1 signal preferentially through TLR2/6. (A) HEK 293 cells stably expressing TLR2, 4, 2/1, 2/6 or TLR4-CD14-MD2 were
stimulated with 1 mg/ml of rFimA, rMfa1, the classic TLR2-specific agonist, Pam3CSK4 or the classic TLR4-specific agonist E. coli LPS. IL-8 release was
quantified in 20 hr cell-free supernatants by ELISA. n.d. = not detected (below assay threshold); *p,0.05; **p,0.01; ***p,0.001. (B) THP-1 Blue cells
are stably transfected with a reporter plasmid expressing secreted embryonic alkaline phosphatase (SEAP) gene under the control of a NF-kB-
inducible promoter. THP-1 Blue cells were stimulated with 1 mg/ml of rFimA, rMfa1, Pam3CSK4 or E. coli LPS. Relative expression levels of SEAP
(reflecting NF-kB) in cell-free supernatants were determined by spectrophotometric analysis of SEAP activity at 655 nm. Unstimulated cells represent
the 100% control. Here we show that all TLR-agonists employed are equally capable of inducing NF-kB. ***p,0.001 compared to unstimulated cells.
doi:10.1371/journal.pone.0009323.g004
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changes in P. gingivalis [28] and, thus, other yet to be identified
mechanisms may well contribute to the overall reduced inflam-
matory response, the anti-inflammatory effects of recombinant
FimA are potent and are likely to be a major factor in CSE-
induced inflammatory suppression.
In summary, CSE-exposure results in the upregulation of FimA.
FimA suppresses the inflammatory response by at least two
different mechanisms. One is passive, i.e. FimA itself engages
TLR2 but has minimal inflammatory potential. The second is
active, i.e., FimA induces TLR2 hyporesponsiveness by a
mechanism involving IRAK-1 degradation and the stabilization
of IkBa.
CSE mediated stress induced alterations in key virulence factors
of P. gingivalis. While down-regulated capsular polysaccharides
increased biofilm formation, upregulated fimbriae promoted
TLR2 hyposensitivity in an IkBa-, IRAK-1- dependent manner.
Both mechanisms, contribute towards altering host-pathogen
interactions and reducing the host-induced inflammatory re-
sponse. This is consistent with our prior observations that CSE-
exposed whole P. gingivalis cells have reduced inflammatory
potential compared to control bacteria [14]. These observations
are also consistent with the clinical profiles of smokers of severe
periodontal disease who lack overt signs of clinical inflammation
[9,10].
Methods
Reagents and antibodies
DMEM, RPMI 1640 and keratinocyte-serum-free (KSF) media,
Dulbecco’s PBS, bovine pituitary extract, Amphotericin B and
Nu-Page 4–12% Bis-Tris gels and all other SDS-PAGE chemicals
were obtained from Invitrogen (Carlsbad, CA). FBS came from
HyClone (Logan, UT). THP-1, THP-1 Blue, TLR-transfected
Human Embryonic Kidney (HEK) 293 and vector control cells as
well as Pam3CSK4, FSL, LPS, normocin, blastocidin, zeocin,
hygrogold and QUANTI-Blue NF-kB assays were purchased from
Invivogen (San Diego, CA). Penicillin–streptomycin came from
Mediatech (Manassas, VA). RIPA buffer, PhosSTOP and
complete Mini EDTA-free protease inhibitor cocktail tablets were
bought from Roche (Indianapolis, IN). BCA Protein Assay kits
came from Pierce (Rockford, IL). SuperSignal West Pico
Chemiluminescent Substrate kits and Bacterial Protein Extraction
Reagent (B-PER) were purchased from Thermo Scientific (Rock-
ford, IL). FimA-specific antibodies were custom generated by
Cocalico Biologicals, Reamstown, PA, while FITC-labeled mouse
anti- human CD16b and mouse IgM-FITC isotype control
antibodies came from AbD Serotec (Oxford, UK). Fibronectin
pre-coated microplates were from BD Biosciences (San Jose, CA).
Anti-P. gingivalis antibodies were generated in house, while HRP-
linked anti-rabbit IgG came from Sigma-Aldrich (St. Louis, MO).
All other antibodies were purchased from Cell Signaling
Technology (Beverly, MA) Gifu anaerobic medium (GAM) was
bought from Nissui Pharmaceuticals (Tokyo, Japan). Lymphocyte
separation medium (LSM) was purchased from MP Biologicals
(Solon, OH). Dextran, PBS and tetramethylbenzidine were
obtained from Fisher Scientific (Fair Lawn, NJ), EDTA from AA
Hoefer Inc. (San Francisco, CA), while trypan blue, insulin,
transferrin, 2-mercaptoethanol, 2-aminoethanol, sodium selenite,
proteinase K acrylic beads and phosphotongstic acid were
purchased from Sigma-Aldrich (St. Louis, MO). HiTrap Chelating
HP affinity columns came from Amersham Biosciences Corp.,
(Piscataway, NJ). Isopropyl-b-D-thiogalactopyranoside (IPTG) was
bought from RPI Corporation (Prospect, IL). Limulus amoebocyte
lysates assay kit was purchased from Cape Cod Inc. (Falmouth,
MA). IL-8 ELISA kits were from Cell Sciences (Canton, MA).
TNF-a, IL-6 and IL-10 ELISA kits and FITC conjugated anti-
human TLR2 and appropriate istoype control antibodies were
purchased from eBioscience (San Diego, CA). Formavar coated
copper grids were from Electon Microscopy Sciences (Hatfield,
PA). Finally, standard reference cigarettes were obtained from
Kentucky Tobacco Research and Development Center (Lexing-
ton, KY).
Porphyromonas gingivalis growth, maintenance, and
cigarette smoke extract (CSE) exposure
Porphyromonas gingivalis W83 and ATCC 33277 were purchased
from the American Type Culture Collection (Manassas, VA) and
maintained as frozen stocks. P. gingivalis was grown in GAM or
GAM conditioned with CSE (GAM-CSE) under anaerobic
conditions (80% N2, 10% H2, 10% CO2)a t3 7 uC in a Coy
Laboratories anaerobic chamber. Bacteria were harvested at mid-
to late-exponential phase (O.D. of 1 corresponds to 10
9 cells ml
21).
Figure 5. FimA induces TLR2-specific innate tolerance. 0.5610
6
primary human PBMCs were pre-incubated with rFimA for 24 hrs before
stimulation with 1 mg/ml of rFimA, rMfa1 or the TLR2 and -4 specific
agonists Pam3CSK4 and E. coli LPS. Responses were compared to cells
treated with the same agonists without any pre-incubation. (A) TNF-a;
(B) IL-6. n.d. = not detected (below assay threshold); ***p,0.001.
doi:10.1371/journal.pone.0009323.g005
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as we have recently described [64]. Briefly, cigarette smoke was
drawn through 50 ml GAM by using a three-way stopcock and a
syringe, with 35 ml ‘drags’ performed over a period of 2 sec, one
drag every 20 sec. Cigarette smoke extract-conditioned medium
was filtered (0.22 mm), and adjusted to pH 7.2. The nicotine
content of GAM-CSE was determined by gas–liquid chromatog-
raphy, as previously described [14] and GAM-CSE adjusted to
physiologically relevant doses [14]. Unless otherwise noted, GAM-
CSE was employed at a concentration of 4000 ng nicotine
Figure 6. FimA induced tolerance reduces Ik-Ba degradation. (A) Human PBMCs were pre-treated with 1 mg/ml rFimA for 24 hrs before
stimulation with 1 mg/ml of rMfa1 for various timepoints. Immunoblots (25 mg protein per well) were probed for IkBa and re-probed b-actin to ensure
equal loading. (B) Mean (s.e.) normalized band intensities.
doi:10.1371/journal.pone.0009323.g006
Figure 7. FimA induced tolerance is IRAK-1-mediated. Human PBMCs were pre-treated (B) or not (A) with 1 mg/ml rFimA for 24 hrs before
stimulation with 1 mg/ml of rMfa1 for various timepoints. Immunoblots (30 mg protein per well) were probed for IRAK-1 and subsequently re-probed
for IkBa and b-actin. (C) Mean (s.e.) normalized band intensities.
doi:10.1371/journal.pone.0009323.g007
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tolerant, with respect to growth and viability, to such CSE doses
[65].
Human PBMC, neutrophil and gingival epithelial cell
isolation and maintenance
Human peripheral blood mononuclear cells (PBMCs) were
isolated from de-identified whole, citrated (10%) venous blood
obtained from healthy donors by separation and collection of
buffy coat and elimination of erythrocyte contamination with
Histopaque 1077 density gradients, as previously described [66].
Written informed consent was obtained from all donors, and
studies performed in compliance with University of Louisville,
Institutional Review Board, Human Subjects Protection Pro-
gram, (study number 503.05). Viability was routinely .98%, as
determined by trypan blue exclusion. PBMCs were maintained in
RPMI-1640 supplemented with 10% heat inactivated FBS,
100u/ml penicillin G and 100 mg/ml streptomycin, at 37uC,
5% CO2. Cells were allowed to rest overnight before addition of
agonists.
Neutrophils were isolated from the erythrocyte-neutrophil
pellet by collection from 1% Dextran- DPBS suspensions and
elimination of erythrocyte contamination by hypotonic lysis. On
restoring isotonicity, cells were washed once with cold DPBS and
once with plasma buffer (2% plasma in DPBS). Neutrophils were
suspended in RPMI-1640 supplemented with 10% heat inacti-
vated FBS, 100 u/ml penicillin G and 100 mg/ml streptomycin,
at 37uC, 5% CO2. Viability was routinely .98%, as determined
by trypan blue exclusion. Purity of neutrophils was routinely $
95%, as determined by flow cytometry using FITC-labeled anti-
CD16b.
The human gingival epithelial cell line, OBA-9, was obtained
from Dr. Denis Kinane (University of Pennsylvania, PA) and
maintained at 37uC, 5% CO2 in KSF medium supplemented with
10 mg/ml of insulin, 5 mg/ml of transferrin, 10 mM 2-mercapto-
ethanol, 10 mM of 2-aminoethanol, 10 nM of sodium selenite,
50 mg/ml of bovine pituitary extract, 100 units/ml of penicillin/
streptomycin and 50 ng/ml Amphotericin B.
Analysis of capsule production and FimA expression on
CSE-exposure
Mid- to late-log P. gingivalis, grown in GAM or GAM-CSE, were
mounted on a formvar-coated copper grid, negatively stained with
phosphotungstic acid at pH 7.0, and the bacteria visualized using
a Philips CM-10 Transmission Electron Microscope. Total P.
gingivalis lysate (1610
5 mid-late log cells) for Western blots were
obtained from cells passaged twice in GAM, twice in GAM-CSE,
or twice in GAM-CSE then reconditioned in fresh GAM. Western
blots were probed with rabbit anti-FimA sera and HRP-linked
anti-rabbit IgG. Immunoreactive bands were visualized by
chemiluminescence. Imaging and densitometry were performed
using the Kodak 4000MM Image station.
Analysis of FimA binding activity and surface availability
Adhesion of mid- to late log phase CSE-exposed and control P.
gingivalis cells to the extracellular matrix protein and FimA ligand,
fibronectin, was measured by ELISA using fibronectin coated
microplates, rabbit anti-P. gingivalis antibody followed by HRP-
linked anti-rabbit IgG antibody and tetramethylbenzidine as the
chromogenic substrate, essentially as previously described by
Pierce et al [67]. Similarly, surface accessibility of FimA presented
on mid- to late log phase CSE-exposed and control P. gingivalis cells
was estimated by ELISA using rabbit anti-FimA antibody.
Analysis of P. gingivalis biofilm formation
Formation of mono-species P. gingivalis biofilms was examined
using a similar procedure to that described by Daep et al for bi-
species biofilms [68]. Briefly, P. gingivalis cultures grown to late log
phase either in GAM or GAM-CSE were introduced into BST FC
71 flow cells (Biosurface Technologies Corp., Bozeman, MT) with
saliva coated cover slips at a flow rate of 6 ml/hr for 2 hr. Flow
was maintained using a Manostat Carter 4/8 cassette peristaltic
pump (Fisher Scientific, Suwanee, GA). Bacteria were then fed
with either GAM or GAM-CSE for 48 hr. Resulting P. gingivalis
biofilms were visualized by FITC staining. The depth of the FITC-
labeled P. gingivalis biofilm was determined on an Olympus
Fluoview confocal laser scanning microscope (Olympus, Pitts-
burgh, PA) from 5 frames randomly chosen by FluoView
(Olympus, Pittsburgh, PA). Microcolony depth was determined
by performing Z-plane scans from 0 mmt o5 0mm above the cover
glass surface. Biofilm characteristics (depth, total surface area
covered, substratum coverage, average and total thickness) were
computed using Matlab v7.5.0 and Comstat (The Mathworks Inc.,
Natick, MA) [69].
Purification of rFimA and rMfa1
Recombinant FimA and Mfa1 proteins were induced in
Escherichia coli vectors containing FimA or Mfa1 cloned into
pET-30 expression system, as described by Park et al. The C-
terminal penta-histidine tagged recombinant proteins were
induced in Escherichia coli by IPTG and purified using HiTrap
chelating HP affinity columns. Purity of recombinant proteins was
confirmed by SDS-PAGE. The lack of contamination by LPS, or
other inflammatory mediators, was confirmed by several mea-
sures, that is, assessment of pro-inflammatory activity (TNF-a
production by PBMCs) of recombinant proteins digested with
proteinase K attached to acrylic beads; assessment of pro-
inflammatory activity (TNF-a production by PBMCs) of recom-
binant proteins following boiling in 2% SDS; and the limulus
amebocyte lysate assay.
Pro-inflammatory profiling of FimA and Mfa1
PBMCs or neutrophils per well were seeded at 0.5610
6 in 96-
well plates and stimulated with 1 mg/ml rFimA, rMfa1, or TLR-
specific agonists (E. coli LPS, Pam3CSK4 and FSL). TNF-a, IL-6,
and IL-10 (PBMC) and IL-8 (neutrophil) levels were determined in
24 hr supernatants by ELISA. OBA-9 cells were seeded at
0.1610
6 cells per well in 12-well plates. On reaching confluence
(48 hr) the epithelial cells were stimulated with rFimA, rMfa1,
LPS, Pam3CSK4 and FSL. Twenty-four hr OBA-9 culture
supernatants were assayed for IL-8 by ELISA.
TLR-specificity of FimA and Mfa1
Human Embryonic Kidney (HEK) 293 cells expressing either
TLR2/1, TLR2/6, TLR4, TLR4-CD14-MD2 and HEK TLR
null cells were maintained at 37uCi n5 %C O 2 in DMEM medium
supplemented with 10% FBS, 100 mg/ml normocin and 10 mg/ml
blastocidin. TLR4-CD14-MD2 cells were also provided 50 mg/ml
hygrogold. TLR activation in each cell line was measured as IL-8
induction 24 hr post-stimulation with rFimA, rMfa1 or specific
TLR positive control agonists.
Induction of TLR2 tolerance by FimA
To determine if rFimA induced TLR2-specific tolerance,
PBMCs (1610
6 cells per well) were stimulated, or not, with
rFimA (1 mg/ml) in 5 ml polypropylene tubes. 24 hr culture
supernatants were collected, PBMCs washed once with DPBS and
Tobacco and P. gingivalis
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FimA, Mfa1, Pam3CSK4 or E. coli LPS (all 1 mg/ml) for an
additional 24 hrs. TNF-a and IL-6 secretion was measured by
ELISA.
NF-kB induction by FimA and Mfa1
THP-1 Blue cells, maintained at 37uC, 5% CO2 in RPMI
supplemented with heat inactivated FBS, 100 u/ml penicillin G
and 100 mg/ml streptomycin and 200 mg/ml zeocin, were
stimulated with FimA, Mfa1 or TLR agonists in 96 well plates
(0.5610
6 cells per well) for 24 hrs. Nf-kB activation was quantified
by using the QUANTI-Blue assay, according to the manufacturer’s
protocol.
TLR2 surface expression following FimA stimulation
PBMCs (1610
6 cells) were treated with FimA (1 mg/ml) or left
unstimulated for 24 hrs. Surface expression or redistribution of
TLR2 was quantified by flow cytometry using FITC-conjugated
anti-TLR2 and istoype control antibodies.
Involvement of IRAK-1, IRAK-M in FimA-induced TLR2
tolerization
Whole cell lysates from 2.5 million PBMCs stimulated with
1 mg/ml FimA, and unstimulated controls, were prepared using
RIPA lysis buffer with a phosphatase and protease inhibitor
cocktail. Total protein was determined by BCA assay according to
the manufacturer’s protocol. Western blots (30 mg protein) were
probed for IRAK-1, IRAK-M, Ik-Ba and b-actin. Immunoreac-
tive bands were visualized by chemiluminescence. Image analysis
and densitometry were performed using the Kodak 4000MM
Image Station. Bands intensities were normalized to the loading
control (b-actin) and expressed as relative intensities.
Statistical analysis
All experiments were carried out a minimum of three times,
unless otherwise noted. Statistical significance between groups was
evaluated by one-way nonparametric ANOVA and the Tukey
multiple-comparison test using the InStat program (Graph-Pad
Software, San Diego, CA). Differences between groups were
considered significant at the level of P,0.05.
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